Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Total revenue $ 240 $ 101 $ 370 $ 202
Costs of revenue 66 73 146 134
Gross profit 174 28 224 68
Operating expenses:        
Research and development 1,476 1,204 3,128 2,799
General and administrative 993 858 1,849 1,858
Sales and marketing 338 329 732 615
Grant expenses 150 176
Total operating expenses 2,957 2,391 5,885 5,272
Loss from operations (2,783) (2,363) (5,661) (5,204)
Other income (expenses):        
Interest expense (1) (8) (1)
Interest income 2 49 3 96
Loss on disposal of assets (1) (1)
Change in fair value of derivative liabilities 108 (14) 148 (256)
Forgiveness of PPP loan 391
Other income, net 162 130 162 142
Total other income (expense), net 271 164 304 372
Net loss before income taxes (2,512) (2,199) (5,357) (4,832)
Provision for income taxes
Net loss $ (2,512) $ (2,199) $ (5,357) $ (4,832)
Net loss per share – basic and diluted        
Basic – net loss $ (0.10) $ (0.09) $ (0.22) $ (0.20)
Diluted –net loss $ (0.10) $ (0.09) $ (0.22) $ (0.20)
Weighted average common shares outstanding:        
Basic 24,716,558 24,687,916 24,714,403 24,678,084
Diluted 25,078,721 24,687,916 25,080,590 24,678,084
Product [Member]        
Total revenue $ 80 $ 101 $ 181 $ 202
Grant [Member]        
Total revenue $ 160 $ 189